Four notes:
1. First quarter sales grew 65 percent year-over-year, according to a news relese.
2. Bone growth therapy sales grew 14 percent year-over-year. Growth was largely driven from spine and fracture product sales.
3. U.S. spinal implant sales rose 18 percent from the first quarter of 2022. Global spine sales were $149.2 million, an 80.5 percent increase year-over-year.
4. Orthofix saw a net loss of $60.9 million. In the first quarter of 2022, net losses were $4.5 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
